Pharmaceuticals

Drug Development Biotechnology Drug Pricing Acquisitions Manufacturing Drug Manufacturing Vaccine Development Mergers and Acquisitions Market Competition Corporate Governance

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Lilly’s premium price meets a new oral challenger in the GLP‑1 race.

Merck Beats Q4 Forecasts as 2026 Guidance Trails Estimates on Patent Losses

Eli Lilly Chooses Pennsylvania for $3.5 Billion Plant to Produce Weight-Loss Injectables

Medicare GLP-1 Use Surges as CMS Advances Coverage Expansion and Lilly Eyes Q2 Pill Launch

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

Lilly, Repertoire Strike Up-to-$1.93 Billion Autoimmune Drug Pact

AstraZeneca Pledges $15 Billion China Expansion Through 2030

Novartis Unveils Super Bowl Ad Promoting Finger-Free PSA Test, Led by Bruce Arians and Rob Gronkowski

Lilly Strikes Up to $1.12 Billion Pact With Seamless Therapeutics for Hearing‑Loss Gene Editing

Insilico, Qilu Strike Near-$120 Million AI Drug Discovery Pact for Cardiometabolic Therapies

Bristol Myers, Janux Strike Exclusive Deal on Tumor-Activated T-Cell Engager

CEPI Backs Next-Gen Zaire Ebola Vaccine With $30 Million Routed Through MSD

De La Soul Launches Good Health Summit at Morehouse on Feb. 19

Bristol Myers to Use Microsoft’s Imaging Network to Deploy FDA-Cleared AI for Earlier Lung Cancer Detection

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Novo Nordisk Expands Aspect Partnership, Transfers Diabetes Cell Tech as Aspect Takes Lead

Novo’s Wegovy Pill Posts Quick Uptake, Boosting Shares as Oral GLP‑1 Battle Nears

Epcoritamab Improves PFS but Not OS in Phase 3 DLBCL Trial

Samsung Epis Targets 20 Biosimilars by 2030, Adds Six Candidates and Readies First ADC Trial